Benzene is an IARC Group 1 human carcinogen with decades of litigation history. Two distinct tracks: (1) Occupational — refinery and chemical plant workers chronically exposed to benzene who develop leukemia (AML, CLL), myelodysplastic syndrome (MDS), and non-Hodgkin lymphoma. Mature litigation with strong science and established defendant list (BP, ExxonMobil, Shell, Lyondell). (2) Consumer aerosol — Valisure's 2021 independent testing found benzene contamination in Neutrogena sunscreen, Banana Boat, Brut body spray, Dove, and dozens of other aerosol products; multiple FDA recalls followed. Consumer aerosol litigation is in early formation and represents a new high-volume mass tort opportunity.
Benzene is a direct-acting myelotoxin — it is metabolized in bone marrow to reactive metabolites that cause chromosomal damage, strand breaks, and impaired hematopoietic stem cell function. IARC Group 1; EPA confirmed human carcinogen. Dose-response established from occupational cohort studies (minimum 1–2 ppm-years exposure threshold for increased leukemia risk). AML and MDS have the strongest causal link; NHL and CLL also established. Consumer track: aerosol inhalation exposure is the key — biomonitoring studies are developing.
Benzene litigation has two active tracks: (1) Occupational — refinery workers, chemical plant employees, petrochemical workers with chronic benzene exposure causing leukemia, AML, MDS, and NHL. Mature litigation with established science and significant settlement history; ongoing cases primarily in IL, PA, and NJ mass consolidations. (2) Consumer aerosol — catalyzed by 2021 independent testing showing benzene contamination in sunscreens, dry shampoos, body sprays, and deodorants. Valisure (independent pharmacy) petitioned FDA; multiple recalls followed. Consumer aerosol track is in early formation.